Basel, 2002/12/06

Genedata AG, the Swiss-based pioneer in developing innovative computational systems and solutions for genomics-based drug discovery research, today announced, that the company has entered into a business alliance with DigiGenomics Co., Ltd., Taiwan for the distribution of Genedata's software systems in Taiwan and China including Hong Kong. This region is considered to be one of the largest and fastest growing life science markets in the world.

"We consider it to be a great opportunity to introduce Genedata's integrated bioinformatics solutions in this quickly emerging market. As research problems get more and more complex we see a growing need for integrated computational systems comprising scalable software platforms as well as excellent scientific and technical support. Genedata's computational solutions address exactly these market needs. With flexible license models, strong support capabilities, and excellent business connections in greater China, we are quite confident that the partnership between Genedata and DigiGenomics will be very successful and bring great benefits to our customers," said Joey Chen, CEO of DigiGenomics.

"We are delighted to introduce, together with our partner DigiGenomics, our successful computational systems and bioinformatics solutions for genomics- and proteomics-based drug discovery to the Asian-Pacific market. We believe that our offering together with our excellent scientific and technical support will be very beneficial to our future customers and partners in accelerating their life science research processes," adds Adesh Kaul, GendData's Head of Marketing & Sales.

In December this year, Genedata and DigiGenomics will conduct a joint series of scientific workshops in Taiwan. Through collaborative promotion, both companies work together to explore more opportunities in Taiwan, China, and Hong Kong. For further information, please contact laurena@digigenomics.com.